Skrzypczyk Piotr, Mizerska-Wasiak Małgorzata, Jerszow Barbara, Ruszczykowski Paweł, Pańczyk-Tomaszewska Małgorzata
Clin Nephrol. 2017 Jun;87(6):301-309. doi: 10.5414/CN108980.
Evaluation of mean blood pressure values, ambulatory arterial stiffness index (AASI), pulse pressure (PP), blood pressure variability (BPV), and circadian blood pressure rhythm using ambulatory blood pressure monitoring (ABPM) in children with IgA nephropathy and Henoch-Schönlein nephropathy (IgAN/HSN).
In 48 children (29 with IgAN, 19 with HSN) aged 14.04 ± 3.76 years, we evaluated retrospectively 24-hour systolic and diastolic BP (24hSBP, 24hDBP), AASI, PP, systolic and diastolic BPV, and nocturnal BP dip by ABPM, body mass index (BMI) Z-score, medications, and biochemical parameters. The control group (CG) consisted of 20 healthy children aged 13.36 ± 4.12 years.
AASI was 0.369 ± 0.100 in IgAN, 0.346 ± 0.148 in HSN, and 0.300 ± 0.067 in the CG; AASI was significantly (p = 0.009) higher in IgAN vs. CG. PP was higher (P = 0.04) in IgAN vs. HSN. Based on ABPM data, poorly-controlled hypertension was found in 14 of 22 patients (63.6%) with previously diagnosed hypertension. No differences in BPV or nocturnal BP dip were found between the groups. In all children with IgAN/HSN, 24hDBP correlated significantly with proteinuria, cholesterol, triglycerides, and prednisone dose; BMI Z-score correlated with SBPV, DBPV, and PP.
CONCLUSIONS: 1. Children with IgAN have higher arterial stiffness compared to healthy peers. 2. In children with IgAN/HSN, proteinuria and hyperlipidemia are risk factors for elevated diastolic blood pressure, while obesity is a risk factor for increased blood pressure variability and pulse pressure. 3. Pediatric patients with IgAN/HSN require regular ABPM evaluation to allow for early detection of poor pharmacological control of hypertension. .
采用动态血压监测(ABPM)评估IgA肾病和过敏性紫癜性肾炎(IgAN/HSN)患儿的平均血压值、动态动脉僵硬度指数(AASI)、脉压(PP)、血压变异性(BPV)和昼夜血压节律。
对48例年龄为14.04±3.76岁的儿童(29例IgAN患儿,19例HSN患儿)进行回顾性研究,通过ABPM评估其24小时收缩压和舒张压(24hSBP、24hDBP)、AASI、PP、收缩压和舒张压变异性以及夜间血压下降情况,同时评估体重指数(BMI)Z评分、用药情况和生化参数。对照组(CG)由20例年龄为13.36±4.12岁的健康儿童组成。
IgAN组的AASI为0.369±0.100,HSN组为0.346±0.148,CG组为0.300±0.067;IgAN组的AASI显著高于CG组(p = 0.009)。IgAN组的PP高于HSN组(P = 0.04)。根据ABPM数据,在22例先前诊断为高血压的患者中,有14例(63.6%)血压控制不佳。各组之间的BPV或夜间血压下降情况无差异。在所有IgAN/HSN患儿中,24hDBP与蛋白尿、胆固醇、甘油三酯和泼尼松剂量显著相关;BMI Z评分与SBPV、DBPV和PP相关。